Bias Due to Missing SEER Data in D'Amico Risk Stratification of Prostate Cancer
Author:
Affiliation:
1. University of Minnesota, Minneapolis, Minnesota
2. Department of Urology, University of Minnesota, Minneapolis, Minnesota
3. Division of Health Policy and Management, University of Minnesota, Minneapolis, Minnesota
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference16 articles.
1. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era;D'Amico;JAMA,1998
2. Contemporary evaluation of the D'Amico risk classification of prostate cancer;Hernandez;Urology,2007
3. Mayo Clinic validation of the D'Amico risk group classification for predicting survival following radical prostatectomy;Boorjian;J Urol,2008
4. Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/mL;Shao;Arch Intern Med,2010
5. Examining the characteristics of unstaged colon and rectal cancer cases;Worthington;Cancer Detect Prev,2008
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Use of expectant management based on prostate cancer risk and health status: How far are we from a risk-adapted approach?;Urologic Oncology: Seminars and Original Investigations;2023-07
2. Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence;Journal of Clinical Epidemiology;2023-03
3. Contributions of Social Factors to Disparities in Prostate Cancer Risk Profiles among Black Men and Non-Hispanic White Men with Prostate Cancer in California;Cancer Epidemiology Biomarkers & Prevention;2021-11-30
4. The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries;Cancers;2021-02-19
5. Nomogram Models for Predicting Risk and Prognosis of Newly Diagnosed Ovarian Cancer Patients with Liver Metastases - A Large Population-Based Real-World Study;Journal of Cancer;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3